Immunoadsorption
Immunoadsorption is a medical device with 11 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
4
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS
Immunoadsorption in Autoimmune Long COVID
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
Clinical Trials (11)
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS
Immunoadsorption in Autoimmune Long COVID
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
Protein A Immunoadsorption in Dilated Cardiomyopathy (RPIA-DCM)
Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy
Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis
Immunoadsorption vs. Plasmapheresis in the Escalation Therapy of Relapse in Multiple Sclerosis
Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein Glomerulopathy
Study of Immunoadsorption to Treat Severe Atopical Dermatitis Associated With Excessively High Serum IgE Levels
All 11 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 11